TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
GENB

Generate Biomedicines, Inc.

Healthcare · Biotechnology

16.00$ -3.2% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet GENB
Line item 2024 2025
100.0% 100.0%
78.6% 71.0%
34.0% 36.8%
76.0% 67.1%
0.1% 0.0%
184.0% 288.7%
16.7% 24.9%
3.2% 4.5%
1.1% 1.2%
-83.8% -186.6%
-91.3% -204.8%
24.6% 15.2%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?